Skip to main content
Levothyroxine Sodium Tablets IP 62.5 mcg Manufacturer

Levothyroxine Sodium Tablets IP 62.5 mcg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Levothyroxine Sodium Tablets IP 62.5 mcg Manufacturer product packaging

Levothyroxine Sodium Tablets IP 62.5 mcg | Manufacturer

Product image for Levothyroxine Sodium Tablets IP 62.5 mcg Manufacturer; contract manufacturing, oem & quality control.

Product Information

Generic NameLevothyroxine Sodium
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaIP
Product TypeTablet
CategoryThyroid Hormone Replacement
SubcategoryThyroid Hormone Replacement
Active IngredientLevothyroxine Sodium
Strength62.5 mcg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryThyroid Hormone Replacement

Medicine Details & Safety

Short DescriptionHealthy Life Pharma invites contract and third-party manufacturing enquiries for Levothyroxine Sodium Tablets IP 62.5 mcg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.
Approved Uses / Indications1. Therapeutic management of indicated clinical conditions as authorized by clinical compendia. 2. Symptom control and maintenance therapy as part of comprehensive patient treatment regimens.
Full Description

Healthy Life Pharma invites contract and third-party manufacturing enquiries for Levothyroxine Sodium Tablets IP 62.5 mcg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.

Product technical specifications

Generic nameLevothyroxine Sodium
CompositionLevothyroxine Sodium
Strength62.5 mcg
CategoryThyroid Hormone Replacement
PharmacopoeiaIP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Manufacturing capabilities and infrastructure

For Levothyroxine Sodium Tablets IP 62.5 mcg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.

Quality control and assurance

Request the approved finished-product specification for Levothyroxine Sodium Tablets IP 62.5 mcg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.

Primary and secondary packaging

The catalogue pack for Levothyroxine Sodium Tablets IP 62.5 mcg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.

Contract manufacturing and private label

Submit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution.
Dosage InstructionsAdminister orally as directed by the prescribing physician. Swallow whole with water; adhere strictly to the recommended therapeutic regimen and schedule.
Side EffectsCommon: Mild nausea, headache, gastrointestinal discomfort, transient fatigue. Uncommon: Dizziness, dry mouth, mild cutaneous rash, loose stools. Rare: Severe allergic hypersensitivity, acute idiosyncratic reactions.
Warnings and PrecautionsClinical Supervision: Use under qualified medical guidance. Organ Function Monitoring: Perform routine renal and hepatic evaluations during prolonged therapy. Disclose all concurrent medications, allergies, and medical history prior to treatment.
Contraindications1. Known hypersensitivity to Levothyroxine Sodium or tablet inactive ingredients.
2. Severe organ decompensation or acute metabolic crises.
3. Uncontrolled acute systemic disorders without specialized medical monitoring.
Drug Interactions1. Concomitant prescription pharmaceuticals: Potential pharmacokinetic and pharmacodynamic interactions requiring physician review.
2. Central depressants or alcohol: May accentuate adverse neurological or sedative symptoms.
3. Over-the-counter supplements: Consult a clinician before combination.

Frequently Asked Questions

QuestionAnswer
Can I request third-party manufacturing for Levothyroxine Sodium Tablets IP 62.5 mcg?Submit your brand, quantity and packaging requirements for manufacturing feasibility review.
Which pharmacopoeial standard applies for Levothyroxine Sodium Tablets IP 62.5 mcg?The source specification is IP; confirm the required standard before contracting.
What quality tests are applicable for Levothyroxine Sodium Tablets IP 62.5 mcg?Request the approved finished-product specification and batch testing plan.
Can packaging be customized for Levothyroxine Sodium Tablets IP 62.5 mcg?Submit artwork and pack requirements for technical and regulatory review.
How do I request a manufacturing quotation for Levothyroxine Sodium Tablets IP 62.5 mcg?Provide forecast volume, target market, strength and packaging requirements.

Product Hashtags

#Levothyroxine#Manufacturer#PharmaB2B

Related Products

Latest Posts